MustGrow Biologics Corp. (MGROF)
OTCMKTS
· Delayed Price · Currency is USD
0.8140
+0.0271 (3.44%)
May 7, 2025, 4:00 PM EDT
MustGrow Biologics Revenue
In the year 2024, MustGrow Biologics had annual revenue of 398.02K CAD, down -91.55%. MustGrow Biologics had revenue of 118.84K in the quarter ending December 31, 2024, a decrease of -97.48%.
Revenue
398.02K CAD
Revenue Growth
-91.55%
P/S Ratio
146.38
Revenue / Employee
n/a
Employees
n/a
Market Cap
40.49M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| The Monarch Cement Company | 268.05M |
| Rubber Leaf | 6.93M |
| Cardinal Ethanol, LLC | 350.34M |
| Venator Materials | 1.56B |
| Gold Reserve | 3.17M |
| Verde Resources | 216.80K |
| Webco Industries | 575.71M |
MustGrow Biologics News
- 5 weeks ago - MustGrow Adds New Biostimulants and Inoculants to Canadian Product Portfolio - Newsfile Corp
- 3 months ago - MustGrow Signs Exclusive Distribution Agreement with Adjuvants Plus Inc. for Biological Product Line - Newsfile Corp
- 4 months ago - MustGrow Announces Closing of Private Placement of Units for $2,585,000 - Newsfile Corp
- 4 months ago - MustGrow Biologics Completes Acquisition of NexusBioAg - Newsfile Corp
- 5 months ago - MustGrow Biologics Announces Proposed Private Placement of Units for Approximately $2 Million - Newsfile Corp
- 5 months ago - MustGrow Biologics Signs Non-Binding Term-Sheet for Acquisition of NexusBioAg - Newsfile Corp
- 8 months ago - MustGrow Provides 2024 Pipeline Update - Newsfile Corp
- 8 months ago - MustGrow Receiving Funding from Agriculture and Agri-Food Canada for Human and Animal Health Applications - Newsfile Corp